Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (Fourth Edition)
No votes yet
Member Price: $149.00Nonmember Price: $225.95
Oncology Nursing Society
Includes table of contents, foreword, and preface.
Chapter 1 provides an overview of healthy and malignant cell growth, describes the role of the immune system in managing cellular growth, explains the effect of chemotherapy on cells, and reviews how treatment responses are determined.
Chapter 2 details the pharmacologic principles of antineoplastic agents, including treatment goals and classification of agents.
Chapter 3 details the study of pharmacogenomics - a branch of precision medicine - in relationship to chemotherapy.
Chapter 4 examines the principles and standards of antineoplastic therapy administration.
Chapter 5 exmaines issues surrounding the administration of hazardous drugs in the perioperative setting.
Chapter 6 addresses a variety of approved immunotherapies, including their molecular targets, FDA-approved indications, and management of adverse events.
Chapter 7 details targeted therapy: small molecule inibitors, including identifying molecular targets and an examination of toxicities.
Chapter 8 provides nearly 600 pages of A-Z listing of antineoplastic agents. As treatments for cancers evolve rapidly, this chapter provides a resource for the clinical practitioner on medications used in the treatment of individuals with cancer.
Chapter 9 reviews chemotherapy regimens currently used for the treatment of specific tumors in adults. Note: As advances are made in cancer treatment, the regimens described within this chapter will continue to evolve.
Chapter 10 details issues surrounding stem cell transplantation science and practice.
Chapter 11 details issues surrounding clinical trials.
Chapter 12 details strategies designed to improve adherence to oral cancer therapies.
Chapter 13 examines issues surrounding symptom management of the patient with cancer.
Chapter 14 details the intimacy and sexuality concerns of patients receiving chemotherapy.
Chapter 15 details issues surrounding the late effects of chemotherapy.
Chapter 16 details issues surrounding the support of cancer survivors.
Chapter 17 explains issues surrounding how to maximize outpatient reimbursement for antineoplastic agents.
Chapter 18 examines legal issues in cancer care.
Chapter 19 details issues surrounding complementary and alternative medicine therapies in oncology practice.
Chapter 20 examines issues surrounding botanicals in cancer care.
Chapter 21 examines access device planning, selection, education, and placement.
Chapter 22 examines issues surrounding biosimiliars.
Chapter 23 examines how patient care outcomes can be improved through navigation.
Chapter 24 details issues surrounding patient and family support during and after cancer therapy.
Chapter 25 offers public and professional cancer resources.
Included is the book's index.